Home›People›Samuel Myllykangas
SM

Samuel Myllykangas

CEO & Co-founder, director at SwitchPoint Bio Holding.

ExecutiveDirector
Updated Nov 11, 2026·Latest SEC filing Mar 10, 2026·Suggest an edit

About Samuel Myllykangas

Samuel Myllykangas is CEO & Co-founder, director at SwitchPoint Bio Holding.

Experience

This experience comes from Samuel Myllykangas's profile and from SEC filings. For roles taken from filings, the years are when the filings name Samuel Myllykangas in the role, so the role may have started earlier or lasted longer.

SwitchPoint Bio Holding, Inc. Current
CEO & Co-founder, director
2026 – Present · Wilmington, DE
Analyzes blood cell biology for drug developers and clinical researchers.
Quest Diagnostics
Vice President
2021 – 2025
Blueprint Genetics
Managing Director
2011 – 2025
University of Helsinki
Adjunct Professor
2001 – 2020
Stanford University
Postdoctoral fellow
2009 – 2011
Biohit Diagnostics
Researcher
1998 – 2001

Key Colleagues at Startups

The people Samuel Myllykangas works with at each company, as listed on that company's latest Form D.

SwitchPoint Bio Holding, Inc. · Form D, Mar 10, 2026
JP
Jussi Paananen
CTO & Co-founder, director
DP

Sources

  1. SECSwitchPoint Bio Holding, Inc. Form D, filed Mar 10, 2026